Publications

2017


Spitzwieser M, Entfellner E, Werner B, Pulverer W, Pfeiler G, Hacker S et al. Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients. BMC CANCER. 2017 Apr 12;17(1):260. doi: 10.1186/s12885-017-3244-2

Rössner B, Klingler M, Bulat T, Sase A, Zeilinger A, Spitzwieser M et al. Hippocampal GluA2 and GluA4 protein but not corresponding mRNA and promoter methylation levels are modulated at retrieval in spatial learning of the rat. Amino Acids. 2017 Jan;49(1):117-127. doi: 10.1007/s00726-016-2335-8

2016



Spitzwieser M, Pirker C, Koblmueller B, Pfeiler G, Hacker S, Berger W et al. Promoter methylation patterns of ABCB1, ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients. Onco Target. 2016 Nov 8;7(45):73347-73369. doi: 10.18632/oncotarget.12332

Englinger B, Loetsch D, Pirker C, Mohr T, van Schoonhoven S, Boidol B et al. Acquired nintedanib resistance in FGFR1-driven small cell lung cancer: role of endothelin-A receptor-activated ABCB1 expression. Onco Target. 2016 Aug 2;7(31):50161-50179. doi: 10.18632/oncotarget.10324


Kryeziu K, Pirker C, Englinger B, van Schoonhoven S, Spitzwieser M, Mohr T et al. Chronic arsenic trioxide exposure leads to enhanced aggressiveness via Met oncogene addiction in cancer cells. Onco Target. 2016 May 10;7(19):27379-27393. doi: 10.18632/oncotarget.8415

2015